Next Article in Journal
Daphne jejudoensis Attenuates LPS-Induced Inflammation by Inhibiting TNF-α, IL-1β, IL-6, iNOS, and COX-2 Expression in Periodontal Ligament Cells
Previous Article in Journal
Polyphenols as Inhibitors of Antibiotic Resistant Bacteria—Mechanisms Underlying Rutin Interference with Bacterial Virulence
Previous Article in Special Issue
Adipose Tissue-Derived Mesenchymal Stem Cells as a Potential Restorative Treatment for Cartilage Defects: A PRISMA Review and Meta-Analysis
 
 
Review

Lineage Differentiation Potential of Different Sources of Mesenchymal Stem Cells for Osteoarthritis Knee

1
Research Fellow, Fellowship in Orthopaedic Rheumatology (FEIORA), Dr. Ram Manohar Lohiya National Law University, Lucknow 226010, Uttar Pradesh, India
2
Indian Stem Cell Study Group (ISCSG) Association, Lucknow 110048, Uttar Pradesh, India
3
Department of Orthopaedics, Mallika Spine Centre, Guntur 522001, Andhra Pradesh, India
4
Department of Orthopaedics, Atlas Hospitals, Tiruchirappalli 620002, Tamil Nadu, India
5
Department of Orthopaedics, Government Medical College, Mahabubabad 506104, Telangana, India
6
Department of Orthopaedics, Faculty of Medicine—Sri Lalithambigai Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai 600095, Tamil Nadu, India
7
Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida 201306, Uttar Pradesh, India
8
Orthopaedic Research Group, Coimbatore 641001, Tamil Nadu, India
9
Department of Medicine, Sri Venkateshwaraa Medical College Hospital and Research Centre, Puducherry 605102, Puducherry, India
10
Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Korea
11
Department of Orthopaedics, Government Medical College and Hospital, Dindigul 624001, Tamil Nadu, India
12
Department of Orthopaedics, Prasad Institute of Medical Sciences, Lucknow 226010, Uttar Pradesh, India
13
Department of Plastic and Reconstructive Surgery, CMRI, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Korea
14
BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu 41944, Korea
*
Authors to whom correspondence should be addressed.
Academic Editors: Madhu S. Dhar and Austin Bow
Pharmaceuticals 2022, 15(4), 386; https://doi.org/10.3390/ph15040386
Received: 31 December 2021 / Revised: 11 March 2022 / Accepted: 17 March 2022 / Published: 22 March 2022
(This article belongs to the Special Issue Cell-Based Therapies for Bone and Cartilage Regeneration)
Tissue engineering and regenerative medicine (TERM) have paved a way for treating musculoskeletal diseases in a minimally invasive manner. The regenerative medicine cocktail involves the usage of mesenchymal stem/stromal cells (MSCs), either uncultured or culture-expanded cells along with growth factors, cytokines, exosomes, and secretomes to provide a better regenerative milieu in degenerative diseases. The successful regeneration of cartilage depends on the selection of the appropriate source of MSCs, the quality, quantity, and frequency of MSCs to be injected, and the selection of the patient at an appropriate stage of the disease. However, confirmation on the most favorable source of MSCs remains uncertain to clinicians. The lack of knowledge in the current cellular treatment is uncertain in terms of how beneficial MSCs are in the long-term or short-term (resolution of pain) and improved quality of life. Whether MSCs treatments have any superiority, exists due to sources of MSCs utilized in their potential to objectively regenerate the cartilage at the target area. Many questions on source and condition remain unanswered. Hence, in this review, we discuss the lineage differentiation potentials of various sources of MSCs used in the management of knee osteoarthritis and emphasize the role of tissue engineering in cartilage regeneration. View Full-Text
Keywords: mesenchymal stem cells; chondrogenesis; tissue engineering; cartilage; osteoarthritis mesenchymal stem cells; chondrogenesis; tissue engineering; cartilage; osteoarthritis
Show Figures

Figure 1

MDPI and ACS Style

Prajwal, G.S.; Jeyaraman, N.; Kanth V, K.; Jeyaraman, M.; Muthu, S.; Rajendran, S.N.S.; Rajendran, R.L.; Khanna, M.; Oh, E.J.; Choi, K.Y.; Chung, H.Y.; Ahn, B.-C.; Gangadaran, P. Lineage Differentiation Potential of Different Sources of Mesenchymal Stem Cells for Osteoarthritis Knee. Pharmaceuticals 2022, 15, 386. https://doi.org/10.3390/ph15040386

AMA Style

Prajwal GS, Jeyaraman N, Kanth V K, Jeyaraman M, Muthu S, Rajendran SNS, Rajendran RL, Khanna M, Oh EJ, Choi KY, Chung HY, Ahn B-C, Gangadaran P. Lineage Differentiation Potential of Different Sources of Mesenchymal Stem Cells for Osteoarthritis Knee. Pharmaceuticals. 2022; 15(4):386. https://doi.org/10.3390/ph15040386

Chicago/Turabian Style

Prajwal, Gollahalli Shivashankar, Naveen Jeyaraman, Krishna Kanth V, Madhan Jeyaraman, Sathish Muthu, Sree Naga Sowndary Rajendran, Ramya Lakshmi Rajendran, Manish Khanna, Eun Jung Oh, Kang Young Choi, Ho Yun Chung, Byeong-Cheol Ahn, and Prakash Gangadaran. 2022. "Lineage Differentiation Potential of Different Sources of Mesenchymal Stem Cells for Osteoarthritis Knee" Pharmaceuticals 15, no. 4: 386. https://doi.org/10.3390/ph15040386

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop